Prophylaxis against respiratory viral disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation;Profilaxis de infección por virus respiratorios en niños y adultos sometidos a trasplante de órganos sólidos y precursores hematopoyéticos

Revista Chilena de Infectologia

Volumn 29, Issue SUPPL.1, 2012, Pages 33-36

  Álvarez, Ana M ^a   Catalán, Paula ^b   Alba, Andrea ^d   Zubieta, Marcela ^c  

^a HOSPITAL SAN JUAN DE DIOS   (Chile)

^b HOSPITAL LUIS CALVO MACKENNA   (Chile)

^c Pediatra Reumatólogo Unidad Inmuno Reumatología Hospital Dr Exequiel González Cortés   (Chile)

^d NONE

Author keywords

Adenovirus; Hematopoietic stem cells transplantation; Influenza virus; Prophylaxis; Respiratory virus; Solid organ transplantation; Syncycial respiratory virus; Transplant

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR;

ADENOVIRUS INFECTION; ADULT; CHILD; DRUG ADMINISTRATION; HUMAN; INCIDENCE; INFLUENZA; ORGAN TRANSPLANTATION; PARAMYXOVIRUS INFECTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION; VIROLOGY;

ADENOVIRIDAE INFECTIONS; ADULT; ANTIVIRAL AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; HUMANS; INCIDENCE; INFLUENZA, HUMAN; ORGAN TRANSPLANTATION; OSELTAMIVIR; PARAMYXOVIRIDAE INFECTIONS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS; STEM CELL TRANSPLANTATION;

EID: 84869395246     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182012000500006     Document Type: Article

References (41)

1. Ison M G. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43: 331-9.
2. Ison M G, Green M. Adenovirus in solid organ transplant recipients. Am J Transplant 2009; 9 Suppl 4: S161-5.
3. Michaels M G, Green M, Wald E R, Starzl T E. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992; 165: 170-4.
4. Ohori N P, Michaels M G, Jaffe R, Williams P, Yousem SA. Adenovirus pneumonia in lung transplant recipients. Human Pathol 1995; 26: 1073-9.
5. Feuchtinger T, Richard C, Pfeiffer M, Neuhauser F, Lucke J, Handgretinger R, et al. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klin Padiatr 2005; 217: 339-44.
6. van Tol M J, Kroes AC, Schinkel J, Dinkelaar W, Claas E C, Jol-van der Zijde C M, et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 2005; 36: 39-50.
7. Walls T, Hawrami K, Ushiro-Lumb I, Shingadia D, Saha V, Shankar AG. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? Clin Infect Dis 2005; 40: 1244-9.
8. Feuchtinger T, Lang P, Handgretinger R. Adenovirus infection after allogeneic stem cell transplantation. Leuk Lymphoma 2007; 48: 244-55.
9. Lee I, Barton T D. Viral respiratory tract infections in transplant patients: epidemiology, recognition and management. Drugs 2007; 67: 1411-27.
10. Ison M G. Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation. Curr Opin Oncol 2009; 21: 171-6.
11. Ison M G, Michaels M G. RNA respiratory viral infections in solid organ transplant recipients. Am J Transplant 2009; 9 Suppl 4: S166-72.
12. Chatzidimitriou D, Gavriilaki E, Sakellari I, Diza E. Hematopoietic cell transplantation and emerging viral infections. J Med Virol 2010; 82: 528-38.
13. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 2008; 143: 455-67.
14. Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D, et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46: 402-12.
15. Ljungman P. Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant 2001; 7 Suppl: 5S-7S.
16. Anderson E J, Guzmán-Cottrill J A, Kletzel M, Thormann K, Sullivan C, Zheng X, et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant 2008; 12: 219-27.
17. Kalpoe J S, van der Heiden P L, Barge R M, Houtzager S, Lankester A C, van Tol M J, et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol 2007; 78: 314-21.
18. Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K, et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51-7.
19. Fischer S A. Emerging viruses in transplan-tation: there is more to infection after transplant than CMV and EBV. Transplantation 2008; 86: 1327-39.
20. Chemaly R F, Ghosh S, Bodey G P, Rohatgi N, Safdar A, Keating M J, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplan-tation recipients: a retrospective study at a major cancer center. Medicine 2006; 85: 278-87.
21. Chakrabarti S, Collingham K E, Holder K, Fegan C D, Osman H, Milligan D W. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Bone Marrow Transplant 2001; 28: 759-63.
22. Boeckh M, Englund J, Li Y, Miller C, Cross A, Fernández H, et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 2007; 44: 245-9.
23. Adams R H. Pre emptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin. Biol Blood Marrow Transplant 2001; 7 Suppl: 16S-8S.
24. Adams R, Christenson J, Petersen F, Beatty P. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Bone Marrow Transplant 1999; 24: 661-4.
25. Ghosh S, Champlin R E, Englund J, Giralt S A, Rolston K, Raad I, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751-5.
26. Chavez-Bueno S, Mejías A, Merryman R A, Ahmad N, Jafri H S, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 2007; 26: 1089-93.
27. Thomas N J, Hollenbeak C S, Ceneviva G D, Geskey J M, Young M J. Palivizumab prophylaxis to prevent respiratory syncytial virus mortality after pediatric bone marrow transplantation: a decision analysis model. J Pediatr Hematol Oncol 2007; 29: 227-32.
28. Cortez K, Murphy B R, Almeida K N, Beeler J, Levandowski R A, Gill VJ, et al. Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation. J Infect Dis 2002; 186: 834-8.
29. Zaia J, Baden L, Boeckh M J, Chakrabarti S, Einsele H, Ljungman P, et al. Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009; 44: 471-82.
30. Siegel J D, Rhinehart E, Jackson M, Chiarello L. Guidelines for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J infect Control 2007; 35: S65-164.
31. Ison M G, Hirsch H H. Influenza: a recurrent challenge to transplantation. Transpl Infect Dis; 12: 95-7.
32. Sandherr M, Einsele H, Hebart H, Kahl C, Kern W, Kiehl M, et al. Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 2006; 17: 1051-9.
33. Fiore A E, Shay D K, Broder K, Iskander J K, Uyeki T M, Mootrey G, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008; 57: 1-60.
34. Kunisaki K M, Janoff E N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 493-504.
35. Kumar D, Morris M I, Kotton C N, Fischer S A, Michaels M G, Allen U, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010; 10: 18-25.
36. Dutkowski R. Oseltamivir in seasonal influenza: cumulative experience in low-and high-risk patients. J Antimicrobial Chemother 2010; 65 Suppl 2: ii11-ii24.
37. La Rosa A M, Champlin R E, Mirza N, Gajewski J, Giralt S, Rolston K V, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871-6.
38. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007; 13: 74-81.
39. Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 2004; 23: 583-8.
40. Echavarria M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 2008; 21: 704-15.
41. Walls T, Shankar A G, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 2003; 3: 79-86.